(19)

(11)

EP 4 189 641 A1

(12)

(43) Date of publication: 07.06.2023 Bulletin 2023/23 (21) Application number: 21849802.0 (22) Date of filing: 19.07.2021

(51) International Patent Classification (IPC):  G06T 7/00(2017.01) G06K 9/00(2022.01) (52) Cooperative Patent Classification (CPC): G06T 2207/30072; G06T 2207/20081; G06T 7/0012; G06V 10/52; G06V 10/431; G06V 10/806; G06V 10/7753 (86) International application number: PCT/US2021/042139 (87) International publication number: WO 2022/026226 (03.02.2022 Gazette 2022/05)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 27.07.2020 US 202016940320 27.07.2020 US 202016940325 (71) Applicant: Recursion Pharmaceuticals, Inc. Salt Lake City, UT 84101 (US)

(72) Inventors: FOGELSON, Benjamin Marc Feder Salt Lake City, Utah 84101 (US) MCLEAN, Peter Salt Lake City, Utah 84101 (US) HAQUE, Imran Salt Lake City, Utah 84101 (US) SAUNDERS, Marissa Salt Lake City, Utah 84101 (US) FISH, Eric Salt Lake City, Utah 84101 (US) BAKER, Charles Salt Lake City, Utah 84101 (US) RODRÍGUEZ VERA, Juan Sebastián Salt Lake City, Utah 84101 (US) (74) Representative: Morrall, Jonathan Ian McLachlan et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL London WC1X 8NL (GB)